The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in Alternative Age Groups
Abstract
Authors
E Hancock D Trueman ST Alexopoulos V Gielen
E Hancock D Trueman ST Alexopoulos V Gielen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now